SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-24-023057
Filing Date
2024-05-14
Accepted
2024-05-14 07:17:16
Documents
11
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 6-K a10form6-kxmay142024.htm 6-K 13098
2 EX-99.1 organigramholdingsinc-2mda.htm EX-99.1 779325
3 EX-99.2 organigramholdingsinc-1fsx.htm EX-99.2 578430
4 EX-99.3 a5aceocertification-2024q2.htm EX-99.3 14839
5 EX-99.4 a5bcfocertification-2024q2.htm EX-99.4 14824
6 EX-99.5 organigramholdingsinc-3prx.htm EX-99.5 189619
7 a2023_q1xcoversxback1a.jpg GRAPHIC 163902
8 a2023_q1xcoversxbacka.jpg GRAPHIC 163902
9 blueleafs.gif GRAPHIC 559128
10 q22024coverfsa.jpg GRAPHIC 851175
11 q22024covermdaa.jpg GRAPHIC 823712
  Complete submission text file 0001628280-24-023057.txt   4991118
Mailing Address 35A ENGLISH DR. MONCTON A3 E1E 3X3
Business Address 35A ENGLISH DR. MONCTON A3 E1E 3X3 506-384-1571
ORGANIGRAM HOLDINGS INC. (Filer) CIK: 0001620737 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-38885 | Film No.: 24941443
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)